News

London: The World Health Organization (WHO) is set to officially back the use of weight-loss drugs as a treatment for obesity ...
(Reuters) -European shares inched lower on Monday as investors awaited further details on the U.S.-China trade negotiations, ...
By Sukriti Gupta (Reuters) -European shares were little changed on Monday, as investors awaited details on the U.S.-China ...
Indian equity indices Sensex and Nifty traded higher on Monday, buoyed by easing global trade tensions and continued foreign ...
Volvo Cars' battery company Novo Energy said on Monday it will cut its workforce by 50% to reduce costs after evaluating its ...
Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
The FDA is asking some of its recently fired staff responsible for critically important funding negotiations with drugmakers ...
The pharmaceutical sector is one of the best performing sectors. Sanofi and GSK beat profit expectations, while Novartis and ...
Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
Oil prices tumbled over 2% on Monday after oil producing group OPEC+ agreed to accelerate oil production increases, while Taiwan's dollar surged to almost three-year highs at the start of a central ...
Results showed that 62.9% of patients on Ozempic saw a reduction in liver inflammation, compared to 34.3% on placebo.